UPI: Study: Sickle cell disorder patients less likely to get full COVID-19 vaccine dosage

Sarah L. Reeves, PhD, MPH, of CHEAR was recently quoted by UPI.

"It is essential to develop targeted interventions to increase COVID-19 vaccination among people with sickle cell disease," said the study's principal investigator, Dr. Sarah Reeves.

Reeves said the sickle cell population is being "chronically underserved" by the U.S. healthcare system, and she emphasized the importance of increasing accessibility and the acceptance of COVID-19 vaccines.

Read the full article here - >

More Like This